Breaking News Instant updates and real-time market news.

MDT

Medtronic

$86.21

-0.59 (-0.68%)

, GPS

Gap

$26.06

-0.12 (-0.46%)

07:30
04/17/19
04/17
07:30
04/17/19
07:30

Unusual put flow in option market yesterday

Notable put activity was cited Tuesday in Medtronic (MDT), Gap (GPS), Lumber Liquidators (LL), Cognizant (CTSH), and AMN Healthcare (AMN).

MDT

Medtronic

$86.21

-0.59 (-0.68%)

GPS

Gap

$26.06

-0.12 (-0.46%)

LL

Lumber Liquidators

$11.05

-0.21 (-1.87%)

CTSH

Cognizant

$71.91

-2.41 (-3.24%)

AMN

AMN Healthcare

$48.13

-1.25 (-2.53%)

  • 17

    Apr

  • 30

    Apr

  • 02

    May

  • 08

    May

  • 08

    May

  • 09

    May

  • 18

    May

  • 29

    May

  • 05

    Jun

  • 23

    Jun

MDT Medtronic
$86.21

-0.59 (-0.68%)

04/09/19
SPHN
04/09/19
NO CHANGE
Target $170
SPHN
Overweight
Medtronic outcomes-based program could be headwind for DexCom, says Stephens
After Medtronic (MDT) announced that the company has reached a deal with Blue Cross and Blue Shield of Minnesota on an outcomes-based program for the company's Guardian Connect Continuous Glucose Monitoring system, Stephens analyst Chris Cooley said the program could potentially represent an incremental headwind to Dexcom's (DXCM) revenue growth if applied across a larger setting. However, Cooley is maintaining his calendar 2019 and 2020 estimates for Dexcom and keeps an Overweight rating on shares with a $170 price target.
03/29/19
STFL
03/29/19
NO CHANGE
Target $45
STFL
Buy
IntriCon added to Select List at Stifel
Stifel analyst Jonathan Block said "the past twelve months have certainly been eventful" for IntriCon (IIN) but he contends that the company is "in a much more formidable place than where they were 12 months ago." In terms of potential catalysts over the next twelve months, Block points to a formalization of the company's contract with Medtronic (MDT), changes to the board, the international rollout of 670G and his expectation for a more aggressive Guardian CGM launch in mid-2019. Block, who believes the stock can double from current levels, added IntriCon to the Stifel Select List and keeps a Buy rating and $45 price target on the shares.
03/18/19
WELS
03/18/19
NO CHANGE
Target $202
WELS
Outperform
Edwards Lifesciences price target raised to $202 from $188 at Wells Fargo
Wells Fargo analyst Lawrence Biegelsen raised his price target for Edwards Lifesciences to $202 from $188 after the results of the company's low-risk TAVR trial was presented at the 2019 American College of Cardiology meeting. The analyst sees potential upside to his forecast given the strong low-risk results presented at ACC. Biegelsen reiterates an Outperform rating on the shares.
03/18/19
ADAM
03/18/19
NO CHANGE
Target $215
ADAM
Buy
Edwards Lifesciences price target raised to $215 from $190 at Canaccord
Canaccord analyst Jason Mills maintained a Buy rating on Edwards Lifesciences (EW) and raised his price target to $215 from $190 after the PARTNER 3 trial delivered superiority to surgery. In a research note to investors, Mills says he thinks the data will give Edwards a definitive marketing advantage in the TAVRmarket, relative to both Medtronic (MDT) and Boston Scientific (BSX), he thinks now has a higher hurdle to clear in TAVR than pre-Phase 3 data release.
GPS Gap
$26.06

-0.12 (-0.46%)

03/01/19
JEFF
03/01/19
NO CHANGE
Target $50
JEFF
Buy
Gap shares could double on sum-of-the-parts, says Jefferies
Jefferies analyst Randal Konik says his sum-of-the-parts analysis implies shares of Gap could double. He's a buyer of the company after the company announced the spin-off of Old Navy. The analyst keeps a Buy rating on the shares with a $50 price target. Separating Old Navy to a standalone company is what we have argued for over the past few years, Konik tells investors in a research note. He believes the unit should command a greater than 10 times enterprise value to EBITDA multiple.
03/01/19
STPT
03/01/19
DOWNGRADE
STPT
Hold
Gap downgraded to Hold from Buy at Standpoint Research
03/01/19
MKMP
03/01/19
NO CHANGE
Target $33
MKMP
Neutral
Gap price target raised to $33 from $30 at MKM Partners
MKM Partners analyst Roxanne Meyer raised her price target on The Gap to $33 after its Q4 results and Old Navy spinoff, saying it is a "positive strategic development to unlock value for shareholders". The analyst believes that Old Navy will "garner a sizable premium vs. NewCo" because of its "coveted" fundamentals relative to the retail landscape, adding that it has the opportunity to "grow sales from core category strength, new categories, and growth in new smaller markets". Meyer is keeping her Neutral rating on Gap shares however given the questions around the spinoff's dis-synergies, as the company can no longer leverage a tri-brand credit card, web platform, supply chain, and real estate.
04/03/19
STPT
04/03/19
UPGRADE
STPT
Buy
Gap upgraded to Buy from Hold at Standpoint Research
LL Lumber Liquidators
$11.05

-0.21 (-1.87%)

01/03/19
LOOP
01/03/19
DOWNGRADE
Target $10
LOOP
Hold
Lumber Liquidators downgraded to Hold from Buy at Loop Capital
Loop Capital analyst Laura Champine downgraded Lumber Liquidators to Hold and cut her price target for the shares to $10 from $24. The analyst reduced her margin forecast to reflect a promotional environment. In 2019, lower sales and margins are likely as big-ticket home-related spending growth begins to fade, Champine tells investors in a research note. The analyst's 35c earnings per share estimate for Lumber Liquidators's 2019 is 20c lower than the consensus. However, she believes the stock's "trough valuation" should limit further downside.
03/20/19
EVER
03/20/19
INITIATION
Target $10
EVER
In Line
Lumber Liquidators initiated with an In Line at Evercore ISI
Evercore ISI analyst Greg Melich started Lumber Liquidators with an In Line rating and $10 base case price target, stating that its been on a "long road to recovery" and it is still unclear what the "new normal" is for Lumber Liquidators with its margins still below 2% and the stock trading close to an all-time low.
03/12/19
STFL
03/12/19
NO CHANGE
STFL
Lumber Liquidators clears last significant legal hurdle, says Stifel
Lumber Liquidators entered into a deferred prosecution agreement and agreed to a $33M fine in connection with the investigation by the DOJ, SEC, and U.S. Attorney's Office that is associated with the company's Chinese laminate products, noted Stifel analyst John Baugh. The analyst believes this was the company's last significant legal issue, and sees the news as positive as it removes a significant uncertainty moving forward. Baugh maintained a Hold rating on Lumber Liquidators.
01/03/19
01/03/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Hold from Buy at Jefferies and Loop Capital, as well as to Neutral from Outperform at Macquarie. 2. Genesee & Wyoming (GWR) downgraded to Equal Weight from Overweight at Stephens with analyst Justin Long citing his view that a re-expansion in valuation multiples could be more challenging in the near-term given North American volume headwinds in the short line network, unknowns around the PSR impact and more concerning international macro data points. 3. Lumber Liquidators (LL) downgraded to Hold from Buy at Loop Capital with analyst Laura Champine saying she reduced her margin forecast to reflect a promotional environment. 4. American Electric (AEP) downgraded to Neutral from Buy at Mizuho with analyst Paul Fremont citing valuation. 5. AbbVie (ABBV) downgraded to Neutral from Buy at BofA/Merrill with analyst Jason Gerberry saying he sees "limited upside to shares" relative to his price objective and also cites a more "unfavorable macro backdrop for companies with high single product concentration risk." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CTSH Cognizant
$71.91

-2.41 (-3.24%)

04/16/19
WELS
04/16/19
DOWNGRADE
WELS
Market Perform
Cognizant downgraded to Market Perform from Outperform at Wells Fargo
02/07/19
02/07/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Saia (SAIA) upgraded to Buy from Hold at Deutsche Bank with analyst Amit Mehrotra saying after meeting with management, he is incrementally more confident in Saia's ability to generate double-digit revenue growth this year. 2. Guess (GES) upgraded to Buy from Hold at Jefferies with analyst Janine Stichter saying the recent pullback in the stock puts the company's multiple below its historical average and peers. 3. Spirit Airlines (SAVE) upgraded to Buy from Neutral at Goldman Sachs with analyst Catherine O'Brien saying she expects passenger revenue trends for the company in the first half of the year to be stronger than previously anticipated. 4. MacroGenics (MGNX) upgraded to Buy from Sell at Citi with analyst Yigal Nochomovitz saying additional Phase 1 readouts in 2019 should provide further stock momentum for MacroGenics. 5. Cognizant (CTSH) upgraded to Outperform from Market Perform at BMO Capital with analyst Keith Bachman citing the company's FY19 revenue growth outlook and a positive management transition. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/13/19
DAIW
02/13/19
INITIATION
Target $90
DAIW
Buy
Cognizant initiated with a Buy at Daiwa
Daiwa analyst Louis Miscioscia started Cognizant with a Buy rating and $90 price target.
04/16/19
04/16/19
DOWNGRADE
Target $75

Market Perform
Cognizant downgraded to Market Perform on lack of catalysts at Wells Fargo
As previously reported, Wells Fargo analyst Edward Caso downgraded Cognizant to Market Perform from Outperform as he sees no near-term positive catalysts, while operating headwinds persist, including digital, health and banking weakness along with reduced visa availability. The analyst remains surprised that the new CEO was chosen after long-term targets were offered. Caso also lowered his price target on the shares to $75 from $82.
AMN AMN Healthcare
$48.13

-1.25 (-2.53%)

03/28/19
BNCH
03/28/19
NO CHANGE
Target $66
BNCH
Buy
AMN Healthcare outlook improving despite 'speed bumps,' says Benchmark
Benchmark analyst Bill Sutherland noted that AMN Healthcare shares are down 19% year-to-date after missing expectations in Q4 and giving weak Q1 guidance and his recent read of the situation suggests a recovery is likely to be gradual in Q2 and Q3. However, despite these near-term "speed bumps," he sees AMN as positioned for a solid rebound in 2020, given tailwinds from strong MSP wins, improved pricing mix for travel nurses, and better trends in its Other Workforce Solutions. Sutherland keeps a Buy rating and $66 price target on AMN Healthcare shares.
01/23/19
JEFF
01/23/19
NO CHANGE
Target $74
JEFF
Buy
AMN Healthcare price target raised to $74 from $68 at Jefferies
Jefferies analyst Jason Plagman raised his price target for AMN Healthcare Services to $74 and keeps a Buy rating on the shares. A hospital survey makes the analyst incrementally more confident that AMN can deliver mid-single-digit organic growth in 2019-2020 and achieve his above-consensus estimates. He says the survey of 50 hospitals indicates stable temp staffing utilization in 2019 and continued adoption of strategic staffing partnerships.
02/19/19
RHCO
02/19/19
DOWNGRADE
Target $10
RHCO
Hold
Cross Country Healthcare downgraded to Hold from Buy at SunTrust
SunTrust analyst Tobey Sommer downgraded Cross Country Healthcare (CCRN) to Hold and lowered his price target to $10 from $12. The analyst notes that the turnaround plans of the new CEO's will require significant investment, even though he is "highly regarded" in creating shareholder value. Sommer also lowers Cross Country Healthcare revenue growth outlook for this year to -1% from +1% as the company has "chronically under-performed the healthcare staffing market", adding that his decision is independent of the disappointing results of AMN Healthcare's (AMN).
03/06/19
JEFF
03/06/19
NO CHANGE
Target $63
JEFF
Buy
AMN Healthcare selloff brings 'compelling' entry point, says Jefferies
Jefferies analyst Jason Plagman believes the recent pullback in shares of AMN Healthcare creates a "compelling" entry point. The analyst understands the negative reaction to AMN's "disappointing" Q1 guide on February 14, but says continued weakness in the stock over the last two weeks has pushed valuation metrics to levels that have attracted value investors in the past. He remains bullish on the company's longer term outlook and keeps a Buy rating on the shares while lowering his price target to $63 from $68.

TODAY'S FREE FLY STORIES

CURO

Curo Group

$10.96

0.16 (1.48%)

04:55
04/19/19
04/19
04:55
04/19/19
04:55
Conference/Events
Curo Group management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Apr

  • 16

    May

  • 05

    Jun

  • 13

    Nov

04:55
04/19/19
04/19
04:55
04/19/19
04:55
General news
Breaking General news story  »

Week of 4/19 Baker-Hughes…

04:55
04/19/19
04/19
04:55
04/19/19
04:55
General news
Housing Starts Permits to be reported at 08:30 »

March Housing Starts…

04:55
04/19/19
04/19
04:55
04/19/19
04:55
General news
Housing Starts to be reported at 08:30 »

March Housing Starts will…

AON

Aon plc

$175.38

-0.14 (-0.08%)

, MMC

Marsh & McLennan

$93.76

-0.62 (-0.66%)

04:55
04/19/19
04/19
04:55
04/19/19
04:55
Conference/Events
Willis Towers Watson »

Analyst Klauber holds a…

AON

Aon plc

$175.38

-0.14 (-0.08%)

MMC

Marsh & McLennan

$93.76

-0.62 (-0.66%)

WLTW

Willis Towers Watson

$177.37

0.45 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Apr

  • 25

    Apr

  • 26

    Apr

  • 01

    May

  • 07

    May

  • 16

    May

  • 20

    May

  • 11

    Jun

ISRG

Intuitive Surgical

$528.04

3.29 (0.63%)

21:07
04/18/19
04/18
21:07
04/18/19
21:07
Recommendations
Intuitive Surgical analyst commentary at Piper Jaffray »

Intuitive Surgical price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 25

    Apr

  • 03

    May

UBER

Uber

$0.00

(0.00%)

, TM

Toyota

$125.10

0.93 (0.75%)

20:35
04/18/19
04/18
20:35
04/18/19
20:35
Hot Stocks
Uber confirms investment from Toyota, DENSO and SoftBank Vision Fund »

Toyota Motor (TM), Denso…

UBER

Uber

$0.00

(0.00%)

TM

Toyota

$125.10

0.93 (0.75%)

DNZOY

Denso

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

FIX

Comfort Systems USA

$57.58

0.06 (0.10%)

20:08
04/18/19
04/18
20:08
04/18/19
20:08
Hot Stocks
Comfort Systems USA discloses ransomware attack virus »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 12

    Jun

  • 13

    Jun

NSANY

Nissan

$0.00

(0.00%)

, RNSDF

Renault

$0.00

(0.00%)

19:29
04/18/19
04/18
19:29
04/18/19
19:29
Periodicals
Nissan to cut global output by 15% in FY19/20, Nikkei reports »

Nissan Motor (NSANY) will…

NSANY

Nissan

$0.00

(0.00%)

RNSDF

Renault

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FE

FirstEnergy

$40.51

0.28 (0.70%)

19:13
04/18/19
04/18
19:13
04/18/19
19:13
Hot Stocks
FirstEnergy CEO 'pleased' FES submitted revised disclosure statement »

FirstEnergy Corp.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

TSLA

Tesla

$273.25

2.13 (0.79%)

19:03
04/18/19
04/18
19:03
04/18/19
19:03
Periodicals
Tesla CEO, SEC granted one more week to resolve tweet dispute, WSJ says »

Tesla CEO Elon Musk and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 24

    Apr

EXPO

Exponent

$56.39

0.23 (0.41%)

, AKRX

Akorn

$2.77

-0.16 (-5.46%)

18:57
04/18/19
04/18
18:57
04/18/19
18:57
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

EXPO

Exponent

$56.39

0.23 (0.41%)

AKRX

Akorn

$2.77

-0.16 (-5.46%)

ZSAN

Zosano Pharma

$3.41

-0.11 (-3.13%)

FAST

Fastenal

$71.08

0.95 (1.35%)

APHA

Aphria

$7.65

-0.165 (-2.11%)

ISRG

Intuitive Surgical

$528.04

3.29 (0.63%)

PBCT

People's United

$17.12

-0.21 (-1.21%)

I

Intelsat

$19.48

0.235 (1.22%)

LLY

Eli Lilly

$115.20

-1.23 (-1.06%)

PFE

Pfizer

$39.37

-0.5 (-1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 18

    Apr

  • 18

    Apr

  • 23

    Apr

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 30

    Apr

  • 30

    Apr

  • 01

    May

  • 01

    May

  • 03

    May

  • 06

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 16

    May

  • 18

    May

  • 05

    Jun

FIVE

Five Below

$141.65

1.82 (1.30%)

18:44
04/18/19
04/18
18:44
04/18/19
18:44
Hot Stocks
Five Below CEO: There is potential for 2,500+ stores in the U.S »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBRT

Liberty Oilfield Services

$16.60

-0.59 (-3.43%)

18:39
04/18/19
04/18
18:39
04/18/19
18:39
Hot Stocks
Liberty Oilfield Services CFO sells 90,000 Class A common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 01

    May

  • 22

    May

VNO

Vornado

$67.02

0.77 (1.16%)

18:37
04/18/19
04/18
18:37
04/18/19
18:37
Hot Stocks
Vornado sells 45% equity in flagship NYC assets to institutional investors »

Vornado announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 16

    May

CHKP

Check Point

$120.01

-9.56 (-7.38%)

18:26
04/18/19
04/18
18:26
04/18/19
18:26
Recommendations
Check Point analyst commentary at Jefferies »

Check Point billings,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

CAG

Conagra Brands

$30.53

0.405 (1.34%)

18:11
04/18/19
04/18
18:11
04/18/19
18:11
Hot Stocks
Conagra Brands director Gregor buys 10K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

UNP

Union Pacific

$176.70

7.5 (4.43%)

17:52
04/18/19
04/18
17:52
04/18/19
17:52
Periodicals
Union Pacific halts construction of $550M facility in Texas, WSJ reports »

Union Pacific has stopped…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 16

    May

SO

Southern Company

$51.95

-0.22 (-0.42%)

17:47
04/18/19
04/18
17:47
04/18/19
17:47
Hot Stocks
Southern Company to sell Nacogdoches Generating Facility for $460M »

Southern Power announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 21

    May

  • 21

    May

TSLA

Tesla

$273.25

2.13 (0.79%)

17:46
04/18/19
04/18
17:46
04/18/19
17:46
Periodicals
Tesla CEO Musk, SEC ask for extension to settle tweet dispute, Reuters says »

Tesla CEO Elon Musk and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 24

    Apr

GLD

SPDR Gold Shares

$120.40

0.09 (0.07%)

17:44
04/18/19
04/18
17:44
04/18/19
17:44
Hot Stocks
SPDR Gold Shares holdings fall to 751.68MT from 752.86MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSW

OneSpaWorld

$13.77

(0.00%)

17:37
04/18/19
04/18
17:37
04/18/19
17:37
Syndicate
Breaking Syndicate news story on OneSpaWorld »

OneSpaWorld files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCHW

Charles Schwab

$45.57

-0.53 (-1.15%)

17:36
04/18/19
04/18
17:36
04/18/19
17:36
Hot Stocks
Charles Schwab EVP Murtagh sells 23.2K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 15

    May

OSW

OneSpaWorld

$13.77

(0.00%)

17:36
04/18/19
04/18
17:36
04/18/19
17:36
Syndicate
Breaking Syndicate news story on OneSpaWorld »

OneSpaWorld files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$0.00

(0.00%)

17:32
04/18/19
04/18
17:32
04/18/19
17:32
Hot Stocks
Sears delays filing 10-K form »

As previously reported on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.